Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Sandra Halliburton, PhD, was appointed to Cleveland Clinic in 1999 as a staff scientist in the Section of Cardiovascular Imaging within the Division of Radiology at Cleveland Clinic. She holds a joint appointment in the Department of Biomedical Engineering at Cleveland Clinic as well as an academic appointment as Adjunct Professor in the Department of Chemical and Biomedical Engineering at Cleveland State University. Dr. Halliburton specializes in computed tomography (CT) and magnetic resonance imaging (MRI) of the heart.
Dr. Halliburton completed her undergraduate work in physics at Hendrix College in Arkansas, where she received multiple scholarships and academic honors, graduating summa cum laude. She received her Masters of Science degree in biomedical engineering from Vanderbilt University in Nashville, Tenn., where she went on to receive her PhD in biomedical engineering. At Vanderbilt, she was awarded a fellowship by the National Science Foundation and a training grant by the National Institutes of Health. She was also inducted into the Tau Beta Pi Engineering Honor Society.
As a cardiac imaging scientist, Dr. Halliburton has developed and implemented novel and state-of-the-art CT and MR imaging and post-processing techniques for clinical cardiac studies. Her primary areas of CT research include patient radiation safety, atherosclerotic plaque characterization, contrast agent enhancement, and coronary artery calcium scoring. Her primary areas of MRI research include flow dynamics and atherosclerotic plaque characterization. Dr. Halliburton has been invited to lecture on her research work and clinical experiences at medical symposia and conferences nationally and internationally. She has authored or co-authored numerous articles and abstracts in leading publications including Radiology, Circulation, the Journal of Computer Assisted Tomography, the Journal of Magnetic Resonance Imaging, and the Annals of Biomedical Engineering, among others.
Dr. Halliburton is a member of the Radiological Society of North America, the American Heart Association, the Society for Cardiovascular Computed Tomography, the North American Society for Cardiovascular Imaging, and the American Roentgen Ray Society and has been selected to serve on many special committees within these societies. In addition, she serves as an Associate Editor for the Journal of Cardiovascular Computed Tomography and as a reviewer for numerous other scientific journals. Dr. Halliburton is also a founding member of the International Consortium on Standardization of Cardiac CT and the Certification Board of Cardiovascular Computed Tomography.
Cardiovascular Imaging, computed tomography, magnetic resonance
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 7/24/2013, Dr. Halliburton has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.